List View

By /

Clear

Displaying 1,701 - 1,725 of 2,995

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Oncology Payments Models: Where Are We Going?

Oncology Payments Models: Where Are We Going?

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

Novel Advances in Radiation Oncology Beyond SRS and Proton Therapy: What Is Next?

Novel Advances in Radiation Oncology Beyond SRS and Proton Therapy: What Is Next?

Novel Advances in the Therapy of Kidney and Bladder Carcinomas

Novel Advances in the Therapy of Kidney and Bladder Carcinomas

Ovarian-Uterine & Fallopian Tube Carcinomas

Ovarian-Uterine & Fallopian Tube Carcinomas

New Developments in Sarcoma Therapy

New Developments in Sarcoma Therapy

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

DLBCL & Hodgkin’s Disease

DLBCL & Hodgkin’s Disease

Follicular, Marginal Zone and Mantle Cell NHL: Novel Advances

Follicular, Marginal Zone and Mantle Cell NHL: Novel Advances

Acute Myeloid Leukemia

Acute Myeloid Leukemia

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

CAR-T Cell as Strategy for the Management of Hematologic Malignancies

Multiple Myeloma: Triplet? Quadruplet? What is The Best Frontline Therapy and Next Line after First Relapse?

Multiple Myeloma: Triplet? Quadruplet? What is The Best Frontline Therapy and Next Line after First Relapse?

ADC in Breast Cancer Management

ADC in Breast Cancer Management

Early Stage TNBC: Reviewing Different Strategies and Management

Early Stage TNBC: Reviewing Different Strategies and Management

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

Endocrine Therapy for Early-Stage Breast Cancer: Who Needs More?

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

New Agents and New Applications of Targeted Therapy For Hormone Receptor Positive Breast Cancer

Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy

Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy

Novel Advances in RT for Oligometastatic Disease

Novel Advances in RT for Oligometastatic Disease

How to Combine RT and Immunotherapy Without Compromising Anti-tumor Effect?

How to Combine RT and Immunotherapy Without Compromising Anti-tumor Effect?

Esophageal, Gastric and GE Junction Tumors: What’s New in 2023?

Esophageal, Gastric and GE Junction Tumors: What’s New in 2023?

Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2023

Pancreas, Hepatic and Cholangiocarcinoma: Advances in 2023

Bringing Personalized Medicine to Colorectal Cancers

Bringing Personalized Medicine to Colorectal Cancers